Browse drugs

…pport co-prescribing. We describe our experience of prescribing benralizumab alongside non-SA MAbs at a tertiary centre.Methods We conducted…

…zed to receive one of three treatment strategies: benralizumab, prednisolone, or a combination of both. IOS parameters, including inspirator…

…ric oxide at exacerbation, mean (SD) 54.67 (46.86) 59.5 (43.91) Benralizumab alone treatment, n (%) 25 (28.1) 28 (39.4) Benralizumab and pre…

…umab (28.6%) and dupilumab (14.3%), there were no patients with omalizumab.Conclusion and Relevance 70.8% of corticosteroid dependent pati…

…nt. These findings support the use of eosinophil depletion with benralizumab as an effective steroid sparing treatment for patients with CEP…

…roup at exacerbation (D0) and first clinic visit (D7)Conclusion Prednisolone, unlike benralizumab had no effect on reducing eosinophil count…

…th muscle contraction. The LCs signatures are also modulated by benralizumab.…

…spiratory Questionnaire (mucus: r = 0.45; p = 0.05).Conclusions Benralizumab treatment in SEA was associated with early improvements in airw…

…enralizumab, dupilumab, mepolizumab, omalizumab, reslizumab and tezepelumab, were estimated using Medicine Carbon Footprint Classifier, a s…

…iated with remission at 1 year in a real-world asthma cohort on benralizumab.Methods BenRex is a multicentre study of exacerbations on benra…

…tment.2 Aim To analyse ability of real-world asthma patients on benralizumab to achieve the stringent American remission criteria.Methods Be…

…the only without polysorbate). Consequently, desensitisation to tezepelumab was proposed.Results The content of the commercial pen (CP) (21…